Is Ashland Inc. (ASH) a Buy, Sell, or Hold?
Ashland Inc.
NYSE:ASH
$68.27 USD
$1.53 (2.29%)
- Volume
- 413.99K
- Average Volume
- 1.04M
- Market Capitalization
- $3.13B
- P/E Ratio
- -4.45
- Dividend Yield
- 2.44%
- Price Target
- $62.00
- Year High
- $68.65
- Year Low
- $46.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.11
- Current Ratio
- $3.06
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Guillermo Novo |
| Industry | Chemicals - Specialty |
| Sector | Basic Materials |
| Current Symbol | ASH |
| CUSIP | 044186104 |
| CIK | 0001674862 |
| Web | https://www.ashland.com |
| Phone | 302 995 3000 |
| Currency | USD |
| Employees | 2900 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.79 |
| Payout Ratio | -0.11 |
| Current Ratio | 3.06 |
| Quick Ratio | 1.78 |
| Cash Ratio | 0.87 |
Sales & Book Value
| Annual Sales | $1.82B |
| Price / Sales | 1.73 |
| Cash Flow | 7.29 |
| Price / Cash Flow | 9.36 |
| Price / Book | 1.68 |
Price Target and Rating
| Average Stock Price Forecast | $62.00 |
| High Stock Price Forecast | $75.00 |
| Low Stock Price Forecast | $58.00 |
| Forecast Upside/Downside | 10.11% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 24 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-18.37 |
| Trailing P/E Ratio | -4.45 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | $-845M |
| Net Margin | -39.03% |
| Pretax Margin | -35.10% |
| Return on Equity | -37.54% |
| Return on Assets | -15.69% |
Financials Score
| AltmanZ Score | 1.60 |
| Piotroski Score | 4.00 |
| Working Capital | 814M |
| Total Assets | 4.5B |
| Ebit | -569M |
| Market Cap | 3.04B |
| Total Liabilities | 2.63B |
Poll Results
About Ashland Inc. (NYSE:ASH) Stock
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expert ... ise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
2026-07-14 17:01:00
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p.m.
Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
2026-07-14 17:01:00
WILMINGTON, Del. , July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p. m. ET on Tuesday, July 28, 2026.
2026-06-26 08:00:00
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro
Ashland responds to investor presentation by Ancora Alternatives LLC
2026-06-10 18:07:00
WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders.
Ashland responds to investor presentation by Ancora Alternatives LLC
2026-06-10 18:07:00
WILMINGTON, Del. , June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders.
New Strong Sell Stocks for June 10th
2026-06-10 05:21:05
AOS, APOG and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 10, 2026.
2026-06-09 16:05:00
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora”) today released a presentation (available here) detailing what it believes is a near-term opportunity to realize the intrinsic value of Ashland Inc. (NYSE: ASH) (“Ashland” or the “Company”) through a sale of the Company. Ancora plans to engage in a constructive and open dialogue with Ashland to gauge the Board of Directors' willingness to evaluate the Company's standalone prospects versus a potent.
New Strong Sell Stocks for June 8th
2026-06-08 08:05:14
AMTB, ACA and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2026.
Frequently Asked Questions
-
What is the current Ashland Inc. (ASH) stock price?
-
Ashland Inc.(NYSE:ASH) stock price is $68.27 in the last trading session. During the trading session, ASH stock reached the peak price of $68.65 while $46.3 was the lowest point it dropped to. The percentage change in ASH stock occurred in the recent session was 2.29% while the dollar amount for the price change in ASH stock was $1.53.
-
ASH's industry and sector of operation?
-
The NYSE listed ASH is part of Chemicals - Specialty industry that operates in the broader Basic Materials sector.
-
Who are the executives of ASH?
-
James Minicucci | Senior Vice President & GM of Personal Care
William C. Whitaker | Senior Vice President, Chief Financial Officer & Director of Investor Relations
Alessandra Faccin | Senior Vice President and GM of Life Sciences & Intermediates
Eileen Drury | Senior Vice President & Chief HR Officer
Robin E. Lampkin | Senior Vice President, General Counsel & Secretary -
How many employees does ASH have?
-
Number of ASH employees currently stands at 2900. ASH operates from 8145 Blazer Drive, Wilmington, DE 19808, US.
-
Link for ASH official website?
-
Official Website of ASH is: https://www.ashland.com
-
How do I contact ASH?
-
ASH could be contacted at phone #302 995 3000 and can also be accessed through its website. ASH operates from 8145 Blazer Drive, Wilmington, DE 19808, US.
-
How many shares of ASH are traded daily?
-
The average number of ASH shares traded daily for last 3 months was 1.04M.
-
What is the market cap of ASH currently?
-
The market value of ASH currently stands at $3.13B with its latest stock price at $68.27